New Hepatitis C Drug Made $2.3 Billion in Sales

b_250_0_16777215_00_images_obgrabber_2014-05_f69f38586e.jpgPhotodisc/Thinkstock (NEW YORK) -- Sovaldi, a relatively new hepatitis C drug approved by the FDA in December 2013, far surpassed all estimates by raking in nearly $2.3 billion in revenue in the first quarter of the fiscal year. Bloomberg News reports that California-based Gilead Sciences Inc. beat its expected profit by $1 billion. The drug, which costs $1,000 per pill, was among the most financially successful drug introductions in history.

Read more...

NHTSA Urges Parents Not to Leave Children in Cars

b_250_0_16777215_00_images_obgrabber_2014-05_52590c83a2.jpgiStockphoto/Thinkstock (NEW YORK) -- According to a new report from the National Highway Traffic Safety Administration, at least 44 American children died after being left in unattended vehicles in 2013. The NHTSA is urging parents to "look before [they] lock," in a series of national radio and Internet ads. A recent study by Safe Kids Worldwide showed that 14 percent of parents said they had left a child alone in a parked vehicle despite the risk of heatstroke.

Read more...

Bullying Victims More Likely To Bring Weapons to School

b_250_0_16777215_00_images_obgrabber_2014-05_559601a0ae.jpgiStock/Thinkstock (NEW YORK) -- Adolescent students who are bullied are 31 times more likely to carry a weapon to school compared to those who haven't been victimized, according to new research. In addition, an estimated 200,000 high school students who are bullied bring a gun or knife on campus, experts found. The research was presented Sunday at the Pediatric Academic Societies annual meeting in Vancouver, British Columbia, Canada.

Read more...

Synthetic Marijuana Sends Dozens to the Hospital in Texas

b_250_0_16777215_00_images_obgrabber_2014-05_5a86696149.jpgWendy Galietta/The Washington Post via Getty Images (DALLAS) -- Dozens of people were hospitalized in Texas after smoking a new, over-the-counter synthetic drug meant to mimic marijuana. On Friday, officials in Dallas, Texas said patients overdosed in one day on a product called K-2. Symptoms include sedation, overwhelming anxiety, and even psychosis, ranging in people who were very sedated to very agitated.

Read more...

First Confirmed MERS Patient in US in Stable Condition

b_250_0_16777215_00_images_obgrabber_2014-05_ae36b41dd7.jpgCreatas Images/Thinkstock Photos (CHICAGO) -- The man who brought the first known case of Middle East Respiratory Syndrome into the United States is in an Indiana hospital in stable condition. Dr. LaMar Hasbrouck, Illinois' Public Health Director, told ABC News that the patient is "requiring a little supplemental oxygen," but that he is not on a ventilator.

Read more...